October 8, 2026 - B. Riley Securities, Inc., a leading full-service investment bank, announced it served as the exclusive financial advisor to ChronoScale Holdings Corporation (Nasdaq: CHRN) in the sale of its subsidiary, Ekso Bionics, Inc., to Wandercraft. The transaction closed on September 30, 2026 and brings together two leaders in robotic mobility.
This acquisition combines Wandercraft's expertise in advanced robotics and physical AI and its leadership in EMEA with Ekso Bionics' strong U.S. presence, extensive clinical experience, and commercial reach. Together, they form a leading medical exoskeleton company, offering a broader portfolio of medical exoskeletons spanning the continuum of care, from rehabilitation to everyday personal mobility.
The newly combined portfolio includes two rehabilitation platforms, Atalante X and EksoNR, which currently support patients in standing and walking at more than 700 rehabilitation centers worldwide, and two personal-use exoskeletons, Eve and Indego Personal, for eligible individuals with spinal cord injury. Together, the rehabilitation platforms hold U.S. FDA clearances and CE marking covering stroke, spinal cord injury, multiple sclerosis, and acquired brain injury.
Ekso Bionics is a leading developer of medical exoskeleton solutions that help people stand, walk, and participate more fully in everyday life. The company focuses on improving health and quality of life with advanced robotics designed to restore human function.
Wandercraft is a global robotics company with a proprietary physical AI platform spanning medical and industrial applications. Its portfolio includes Eve™, an FDA-cleared personal exoskeleton; Atalante X™, used in more than 150 rehabilitation and research centers worldwide; and Calvin-40™, an autonomous humanoid designed for heavy lifting and industrial work.
This transaction underscores B. Riley Securities' domain expertise in the healthcare and medical technology sectors. Our dedicated banking team leverages deep industry knowledge, strategic relationships, and transaction execution to maximize value for companies executing strategic divestitures and carve-outs in complex, highly regulated markets.
B. Riley Securities' deal team included Thomas McGlynn, Elise Melconian, Noah Rich, and Adam Huberman.
To learn more about this
transaction or to discuss how B. Riley Securities can assist your company with
its capital markets needs, visit www.brileysecurities.com and connect with us on LinkedIn.
About B. Riley Securities,
Inc.
B. Riley Securities, Inc.
provides a full suite of investment banking and capital markets services to
corporations, financial sponsors, and institutional investors across all
industry verticals. Services include initial and follow-on offerings, debt and equity-linked
solutions, institutional private placements, merger and acquisition (M&A)
advisory, corporate restructuring, and liability management. Widely recognized
for its thematic proprietary equity research, B. Riley Securities offers
clients an extensive network, deep industry expertise, and proven execution
capabilities through its end-to-end platform. For more information, visit www.brileysecurities.com and follow us on LinkedIn.